The FDA has received 19,619 adverse event reports for dogs that name Bedinvetmab.
- 19,619 reports name Bedinvetmab in dogs, which is 2.0% of all 1,001,380 dog reports. A report counts under every active ingredient it names.
- 62% are marked serious and 20% record a death or euthanasia; across all dog reports those figures are 29% and 5.4%.
- 12% are complaints that the product did not work (38% across all dog reports).
- The clinical signs reported most are death by euthanasia, lethargy and ataxia.
- The FDA lists 1 approved animal drug application containing Bedinvetmab for dogs, the earliest approved in 2023.
- None of this is a rate. The FDA data does not record how many dogs were given Bedinvetmab, so it cannot say how often any of this happens.
How the reports break down
| What the reports say | Reports | Share of this medicine's reports | All dog reports |
|---|---|---|---|
| Marked seriousthe FDA record flags the report as serious | 12,120 | 62% | 29% |
| Death or euthanasiathe outcome recorded in the report, with no finding of cause | 3,865 | 20% | 5.4% |
| Did not worka complaint that the product failed to work, which the FDA files as an adverse event | 2,379 | 12% | 38% |
| Seizurea seizure or convulsion is among the clinical signs | 1,796 | 9.2% | 4.4% |
| Not used per labelthe report says the product was not used the way its label directs | 2,562 | 13% | 21% |
Where on the body do the reported signs sit?
Not on the body: Whole body 29% Did not work 7.4%
- Whole body29%death by euthanasia, lethargy, death, limb weakness and 2 more
- Stomach and gut22%vomiting, diarrhoea, not eating, decreased appetite and 2 more
- Thirst and urination21%polydipsia, polyuria, urinary incontinence, urinary tract infection and 1 more
- Brain and nerves16%ataxia, seizure, unable to walk, proprioception deficit
- Did not work7.4%lack of efficacy, partial lack of efficacy
- Heart and breathing3.1%panting
- Blood and organ tests2.6%elevated serum alkaline phosphatase (alp)
Each figure is a share of sign mentions among the 25 signs reported most for Bedinvetmab in dogs. One report can list several signs, so these do not add up to reports. The grouping into body systems is ours; the signs in each group are listed beside it.
Clinical signs reported most
- Death by euthanasia2,511 13%
- Lethargy2,357 12%
- Ataxia1,689 8.6%
- Polydipsia1,687 8.6%
- Vomiting1,608 8.2%
- Seizure1,596 8.1%
- Polyuria1,575 8.0%
- Diarrhoea1,525 7.8%
Reports received per year
Is it approved for dogs?
The FDA lists 1 approved animal drug application containing Bedinvetmab for dogs, the earliest approved in 2023.
| Product | Form | Approved for | First approved | FDA application |
|---|---|---|---|---|
| LibrelaZoetis Inc. | Injectable Solution RX | Dog | 2023 | 141-562 |
What can you do next?
Report counts: FDA Center for Veterinary Medicine adverse event reports, read 11 November 2026 (FDA data last updated 5 October 2026). Approvals: Animal Drugs @ FDA, read 11 November 2026. Counts are reports, not animals and not doses.
Where can you go from this result?
This result is one of 94 in the lookup. Open it in the lookup to set it beside another medicine, or read how the counts were collected.
- Imidacloprid in dogs17,831
- Melarsomine in dogs22,745
- Cyclosporine in dogs15,092
- Lotilaner in dogs12,797
To report a suspected side effect in your own animal, follow how to report an animal drug side effect to the FDA. The FDA explains what a report can and cannot show in openFDA's guide to reading the results.
Compiled by Vincent Wesley Couey, PetMaxxing Research (ORCID 0009-0005-6869-308X). Sources: openFDA animal and veterinary adverse event interface; Animal Drugs @ FDA.